Lines of support at $3, any dip below is a great buying opportunity
Current parabolic SAR looks similar to September's.
Thanks, @DavidLMorris!
---
Thoughts on cprx.
I have been examining Catalyst Pharma for quite some time now and I believe there is substantial upside to with their products. I suspect a price target in the $1.75 to $2.50 by year end.
